Peer Review History
Original SubmissionJune 13, 2022 |
---|
PONE-D-22-16889DORA-compliant measures to assess research quality and impact in biomedical institutions: review of published research, international best practice and Delphi surveyPLOS ONE Dear Dr. Gagliardi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Thank you to the authors for submitting this work to PLOS ONE and for their patience during the review process. I apologize for the delay in securing reviewers. It took time to find reviewers with appropriate expertise and many candidates were unavailable over the summer months. This is a great scoping review and Delphi panel with interesting and useful results. Table 3 and Appendix 5 are very high value. Research impact assessment is an important undertaking. I hope to ultimately see wide adoption of the measures you have identified. Reviewer 2 had only minor comments. Reviewer 1 had more substantial comments on a potential discrepancy in focus between the data arising from the database search and the grey literature search. The reviewer suggested heavily revised framing of the manuscript to accommodate the wider focus of the grey literature data. I did not consider there to be a conceptual mismatch in the focus of the database data and grey literature data. However, please address the reviewers comments and consider minor reframing of some elements of the manuscript to ensure uniformity in the focus of the work. In addition to the reviewers comments I have three suggested revisions: 1.Would it be possible to report the research institutes and/or research domains of the participants? On page 23 line 396 you indicate that the sample included different research disciplines. While you describe sampling from different research backgrounds there is no reporting on the institutes or disciplines of the respondents. Reporting this may strengthen the results as it will show that there was a congruency of ratings across disciplines. This would also dispel potential criticism that the uniformity may have arisen from a homogenous disciplinary background of the participants. If this is not permitted due to the ethical constraints of your data collection, then please indicate so in the manuscript. 2.There may be a typo on page 9 line 191 where you report 49 unique measures. In the rest of the manuscript you report 50 unique measures. 3.Page 8, Line 149: would consider replacing the wording “a wide array of research disciplines” with “multiple research disciplines” as it’s a more reproducible criterion that does not require further definition. ============================== Please submit your revised manuscript by Dec 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Niklas Bobrovitz Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend your authorship list in your manuscript file to include author Himani Boury. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review the paper. I always aim to provide constructive comments that hope to improve the draft paper. I have utilised the PLOS criteria as the basis for review: 1. The study presents the results of original research. Yes. I don't think the research is particularly novel, but the identification of domains from the specified PICO criteria and the Delphi review of the identified domains is original and consequently, contributes original research evidence. 2. Results reported have not been published elsewhere. Not for this study, of which I am aware. 3. Experiments, statistics, and other analyses are performed to a high technical standard and are described in sufficient detail. The scoping review may be sufficient for this form of research and appears to have been conducted in line with PRISMA-Scr guidelines. It would have been preferable for the grey literature to be assessed using the PICO developed for the academic database search. The grey literature contained a higher number of the relevant publications and yet, based on my reading of the text, the review process was separate from the specified PICO and accordingly introduced additional subjectivity, did not align with the PICO process/outcomes, and lost the focus on the research quality and impact assessment domains applied to research performance assessment/promotion. The argument could be made that the wider points drawn from the grey literature are pertinent, but if this was the case, the academic literature should have also drawn this wider remit. As a consequence, the scoping review conflates an historical review of the domains applied in the performance review/assessment process and a broader review of what could be incorporated. The latter component was however excluded from the academic database search and consequently misses a large volume of potentially relevant literature. Given the existing summation of potential domains provided the basis for the Delphi process, it is difficult to see how this could be comprehensively adjusted. Greater clarity regarding the inclusion/exclusion criteria for the grey literature may assist. This conflation is also relevant to the following point and the results, discussion and conclusion issue identified below. The specified aim of the paper is 'to identify and prioritize DORA-compliant measures for assessing research.' This aim is inconsistent with the PICO, which, necessarily in this reviewer's subjective opinion, focuses on 'Personnel Selection/personnel management/employee incentive plans/employee performance appraisal/academic performance/career mobility' i.e. the assessment of researchers within a view to workplace performance appraisal, promotion, etc. I would recommend tightening the aim to reflect this narrower focus and similarly to refine the specified purpose to also reflect the performance context for the relevant measures. 4. Conclusions are presented in an appropriate fashion and are supported by the data. The paper results, discussion and conclusion needs to be carefully reviewed to improve precision and alignment with the PICO focus on researcher performance appraisal. For example, greater clarity is required to explain how Table 1/S6 Appendix links to the aims (or preferably narrower aims that reflect the PICO strategy). 5. The article is presented in an intelligible fashion and is written in standard English. Yes 6. The research meets all applicable standards for the ethics of experimentation and research integrity. Yes 7. The article adheres to appropriate reporting guidelines and community standards for data availability. Yes Additional general points: - As per the critique relating to the drift of focus from research performance assessment/promotion, the title is similarly ambiguous. I would recommend changing the title, aim, purpose, and where possible, the results, discussion and conclusion to this narrower focus. The field of research on research is generally under-researched, the initiative is valuable and the focus on researcher performance assessment is a highly relevant issue. Reviewer #2: The review and Delphi study aimed to identify and prioritize DORA-compliant measures for assessing research quality and impact. Broadly speaking, this work is important and timely as we need better metrics for determining the quality and impact of research. This work has the potential to contribute greatly to the field. Overall, this manuscript is very high quality and meets standard reporting guidelines. It is transparent, thorough, and enjoyable to read. It is difficult to find areas for further improvement; however, I suggest two minor revisions: - Please include search strategy for all databases, the appendix only includes MEDLINE - Line 192 you discuss how eight categories “inductively emerged.” Please describe in detail the methods you used for this inductive process (e.g. how the data were coded, use of thematic analysis, content analysis, if it was independently in duplicate or collaboratively, etc.) ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
DORA-compliant measures of research quality and impact to assess the performance of researchers in biomedical institutions: review of published research, international best practice and Delphi survey PONE-D-22-16889R1 Dear Dr. Gagliardi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Niklas Bobrovitz Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I am very supportive of the emphasis and focus of the research presented in the publication. I am wary of scope creep with respect to the technical aspects of the reviewed documentation, particularly given the journal's, PLOS', focus on rigorous methods and techniques. However, given the journal editor has declared that they do not see a conceptual mismatch between the academic database data and the grey literature data, then I am happy to support publication. Good luck with your future research. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Simon Deeming ********** |
Formally Accepted |
PONE-D-22-16889R1 DORA-compliant measures of research quality and impact to assess the performance of researchers in biomedical institutions: review of published research, international best practice and Delphi survey Dear Dr. Gagliardi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Niklas Bobrovitz Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .